SPHK1 and pulmonary arterial hypertension: According to reports, the sphingosine kinase (SphK)/sphingosine-1-phosphate (S1P)/sphingosine-1-phosphate receptors (S1PR) pathway is involved in a variety of lung diseases including PAH [174].